Q4 2025 13F Holders as of 31 Dec 2025
-
Type / Class
-
Equity / American depositary shares, each representing one equity share
-
Shares outstanding
-
834,731,296
-
Total 13F shares
-
1,624,929
-
Share change
-
-46,879
-
Total reported value
-
$22,789,037
-
Price per share
-
$14.04
-
Number of holders
-
36
-
Value change
-
-$655,763
-
Number of buys
-
14
-
Number of sells
-
9
Institutional Holders of DR REDDYS LABORATORIES LTD - American depositary shares, each representing one equity share (RDY) as of Q4 2025
As of 31 Dec 2025,
DR REDDYS LABORATORIES LTD - American depositary shares, each representing one equity share (RDY) was held by
36 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,624,929 shares.
The largest 10 holders included
MASSACHUSETTS FINANCIAL SERVICES CO /MA/, AUGUSTINE ASSET MANAGEMENT INC, NORDEA INVESTMENT MANAGEMENT AB, SIGNATUREFD, LLC, GREENLEAF TRUST, V-Square Quantitative Management LLC, Frank, Rimerman Advisors LLC, Boston Common Asset Management, LLC, NorthCrest Asset Manangement, LLC, and Arta Finance Wealth Management LLC.
This page lists
36
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.